Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAVERSE: Testosterone Replacement Therapy in Hypogonadal Men
NCT03518034Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of AndroForte in Hypogonadism, sponsored by AbbVie Inc.. Started May 2018; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03518034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03518034.